Medical Properties Trust Inc Financials

MPT

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Piotroski F-Score Neutral

4/9

Medical Properties Trust Inc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-0.10x

For every $1 of reported earnings, Medical Properties Trust Inc generates $-0.10 in operating cash flow ($245.5M OCF vs -$2.4B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

This page shows Medical Properties Trust Inc (MPT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$995.5M

YoY+14.2%

5Y CAGR+3.1%

10Y CAGR+12.3%

Medical Properties Trust Inc generated $995.5M in revenue in fiscal year 2024. This represents an increase of 14.2% from the prior year.

EBITDA

N/A

Free Cash Flow

N/A

Net Income

-$2.4B

YoY-333.1%

Medical Properties Trust Inc reported -$2.4B in net income in fiscal year 2024. This represents a decrease of 333.1% from the prior year.

EPS (Diluted)

$-4.02

YoY-332.3%

Medical Properties Trust Inc earned $-4.02 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 332.3% from the prior year.

Cash & Debt

$332.3M

YoY+32.9%

5Y CAGR-25.6%

10Y CAGR+8.7%

Medical Properties Trust Inc held $332.3M in cash against $8.8B in long-term debt as of fiscal year 2024.

Dividends Per Share

$0.46

YoY-47.7%

5Y CAGR-14.7%

10Y CAGR-5.8%

Medical Properties Trust Inc paid $0.46 per share in dividends in fiscal year 2024. This represents a decrease of 47.7% from the prior year.

Shares Outstanding

600M

YoY+0.2%

5Y CAGR+3.0%

10Y CAGR+13.3%

Medical Properties Trust Inc had 600M shares outstanding in fiscal year 2024. This represents an increase of 0.2% from the prior year.

Gross Margin

92.5%

YoY+5.2pp

5Y CAGR+12.2pp

Medical Properties Trust Inc's gross margin was 92.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 5.2 percentage points from the prior year.

Operating Margin

N/A

Net Margin

-242.1%

YoY-178.3pp

5Y CAGR-286.0pp

10Y CAGR-258.3pp

Medical Properties Trust Inc's net profit margin was -242.1% in fiscal year 2024, showing the share of revenue converted to profit. This is down 178.3 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

MPT Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$995.5M+14.2%	$871.8M-43.5%	$1.5B-0.1%	$1.5B+23.6%	$1.2B+46.2%	$854.2M
Cost of Revenue	$74.2M-32.6%	$110.1M-34.3%	$167.4M+65.0%	$101.4M+236.6%	$30.1M-82.1%	$168.2M
Gross Profit	$921.4M+21.0%	$761.7M-44.6%	$1.4B-4.7%	$1.4B+18.4%	$1.2B+77.7%	$686.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$133.8M-8.1%	$145.6M-9.3%	$160.5M+10.2%	$145.6M+10.6%	$131.7M+36.6%	$96.4M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$417.8M+1.6%	$411.2M+14.5%	$359.0M-2.3%	$367.4M+11.8%	$328.7M+38.2%	$237.8M
Income Tax	$44.1M+133.7%	-$130.7M-333.8%	$55.9M-24.4%	$73.9M+138.1%	$31.1M+1284.9%	-$2.6M
Net Income	-$2.4B-333.1%	-$556.5M-161.7%	$902.6M+37.6%	$656.0M+52.1%	$431.4M+15.2%	$374.7M
EPS (Diluted)	$-4.02-332.3%	$-0.93-162.0%	$1.50+35.1%	$1.11+37.0%	$0.81-6.9%	$0.87

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$237.5M-1.2%	$240.4M+7.4%	$223.8M-3.5%	$231.8M-13.0%	$266.6M-1.8%	$271.3M	N/A	$306.6M
Cost of Revenue	N/A	N/A	$81.4M	N/A	N/A	$40.9M	N/A	N/A
Gross Profit	N/A	N/A	$142.4M	N/A	N/A	$230.4M	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$37.7M+44.0%	$26.2M-37.5%	$41.9M+47.1%	$28.5M-19.4%	$35.3M+5.9%	$33.3M	N/A	$38.1M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$132.4M+2.1%	$129.7M+12.0%	$115.8M+14.1%	$101.5M0.0%	$101.4M-6.7%	$108.7M	N/A	$106.7M
Income Tax	$10.9M+10.9%	$9.8M+3.9%	$9.4M-1.3%	$9.6M-34.3%	$14.6M+33.0%	$10.9M	N/A	$10.1M
Net Income	-$77.7M+21.0%	-$98.4M+16.8%	-$118.3M+71.4%	-$412.8M-28.8%	-$320.6M+63.4%	-$875.6M	N/A	$116.7M
EPS (Diluted)	$-0.13+18.8%	$-0.16+20.0%	$-0.20+70.6%	$-0.68-25.9%	$-0.54+63.0%	$-1.46	N/A	$0.19

MPT Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$14.3B-21.9%	$18.3B-6.9%	$19.7B-4.2%	$20.5B+21.9%	$16.8B+16.3%	$14.5B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$332.3M+32.9%	$250.0M+6.1%	$235.7M-48.7%	$459.2M-16.5%	$549.9M-62.4%	$1.5B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$9.5B-11.3%	$10.7B-3.5%	$11.1B-8.4%	$12.1B+27.3%	$9.5B+27.5%	$7.4B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$8.8B-12.1%	$10.1B-2.0%	$10.3B-9.0%	$11.3B+27.3%	$8.9B+26.2%	$7.0B
Total Equity	$4.8B-36.7%	$7.6B-11.2%	$8.6B+1.8%	$8.4B+15.0%	$7.3B+4.4%	$7.0B
Retained Earnings	-$3.7B-276.5%	-$971.8M-935.7%	$116.3M+232.6%	-$87.7M-22.8%	-$71.4M-186.0%	$83.0M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$14.9B-1.5%	$15.2B+2.0%	$14.9B+3.9%	$14.3B-11.7%	$16.2B-6.4%	$17.3B-5.5%	$18.3B-3.7%	$19.0B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$396.6M-22.2%	$509.8M-24.3%	$673.5M+102.7%	$332.3M-45.2%	$606.5M+170.4%	$224.3M-10.3%	$250.0M-26.5%	$340.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.3B-0.5%	$10.3B+2.2%	$10.1B+6.7%	$9.5B-5.4%	$10.0B-5.6%	$10.6B-0.7%	$10.7B-0.5%	$10.7B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$9.6B-0.3%	$9.6B+1.9%	$9.5B+7.0%	$8.8B-5.6%	$9.4B-7.2%	$10.1B+0.3%	$10.1B-0.9%	$10.2B
Total Equity	$4.7B-3.6%	$4.8B+1.5%	$4.8B-1.5%	$4.8B-21.9%	$6.2B-7.6%	$6.7B-12.2%	$7.6B-7.9%	$8.3B
Retained Earnings	-$4.1B-3.2%	-$4.0B-3.8%	-$3.8B-4.6%	-$3.7B-55.8%	-$2.3B-27.1%	-$1.8B-90.0%	-$971.8M-351.9%	-$215.1M

MPT Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$245.5M-51.5%	$505.8M-31.6%	$739.0M-9.0%	$811.7M+31.4%	$617.6M+25.0%	$494.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$1.3B+154.7%	$517.6M+30.7%	$396.1M+110.3%	-$3.9B-30.9%	-$2.9B+39.7%	-$4.9B
Financing Cash Flow	-$1.5B-45.0%	-$1.0B+24.0%	-$1.3B-145.5%	$2.9B+110.4%	$1.4B-72.2%	$5.0B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	$17.9M	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$18.6M-64.1%	$51.7M+13375.8%	$384K-99.5%	$76.7M+117.5%	$35.3M-52.6%	$74.3M-45.1%	$135.4M-14.4%	$158.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$95.1M-31.6%	-$72.3M+19.1%	-$89.4M-197.5%	$91.7M-92.4%	$1.2B+1108.0%	-$119.3M-170.1%	$170.2M+376.1%	-$61.7M
Financing Cash Flow	-$34.5M+77.7%	-$154.8M-136.3%	$426.3M+527.2%	-$99.8M+88.3%	-$853.5M-3966.4%	$22.1M+105.5%	-$402.7M-504.2%	-$66.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MPT Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	92.5%+5.2pp	87.4%-1.8pp	89.1%-4.3pp	93.4%-4.2pp	97.6%+17.3pp	80.3%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-242.1%-178.3pp	-63.8%-122.3pp	58.5%+16.0pp	42.5%+7.9pp	34.5%-9.3pp	43.9%
Return on Equity	N/A	N/A	10.5%+2.7pp	7.8%+1.9pp	5.9%+0.5pp	5.3%
Return on Assets	-16.9%-13.8pp	-3.0%-7.6pp	4.6%+1.4pp	3.2%+0.6pp	2.6%-0.0pp	2.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.83+0.5	1.32+0.1	1.20-0.1	1.34+0.1	1.21+0.2	1.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	63.6%	N/A	N/A	84.9%	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-32.7%+8.2pp	-40.9%+11.9pp	-52.8%+125.2pp	-178.1%-57.8pp	-120.3%+202.4pp	-322.7%	N/A	38.1%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	1.4%
Return on Assets	-0.5%+0.1pp	-0.7%+0.2pp	-0.8%+2.1pp	-2.9%-0.9pp	-2.0%+3.1pp	-5.1%	N/A	0.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	2.06+0.1	2.000.0	1.99+0.2	1.83+0.3	1.510.0	1.51+0.2	1.32+0.1	1.23
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is Medical Properties Trust Inc's annual revenue?

Medical Properties Trust Inc (MPT) reported $995.5M in total revenue for fiscal year 2024. This represents a 14.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Medical Properties Trust Inc's revenue growing?

Medical Properties Trust Inc (MPT) revenue grew by 14.2% year-over-year, from $871.8M to $995.5M in fiscal year 2024.

Is Medical Properties Trust Inc profitable?

No, Medical Properties Trust Inc (MPT) reported a net income of -$2.4B in fiscal year 2024, with a net profit margin of -242.1%.

What is Medical Properties Trust Inc's earnings per share (EPS)?

Medical Properties Trust Inc (MPT) reported diluted earnings per share of $-4.02 for fiscal year 2024. This represents a -332.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Medical Properties Trust Inc have?

As of fiscal year 2024, Medical Properties Trust Inc (MPT) had $332.3M in cash and equivalents against $8.8B in long-term debt.

What is Medical Properties Trust Inc's gross margin?

Medical Properties Trust Inc (MPT) had a gross margin of 92.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Medical Properties Trust Inc's net profit margin?

Medical Properties Trust Inc (MPT) had a net profit margin of -242.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does Medical Properties Trust Inc pay dividends?

Yes, Medical Properties Trust Inc (MPT) paid $0.46 per share in dividends during fiscal year 2024.

What is Medical Properties Trust Inc's operating cash flow?

Medical Properties Trust Inc (MPT) generated $245.5M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Medical Properties Trust Inc's total assets?

Medical Properties Trust Inc (MPT) had $14.3B in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Medical Properties Trust Inc have outstanding?

Medical Properties Trust Inc (MPT) had 600M shares outstanding as of fiscal year 2024.

What is Medical Properties Trust Inc's debt-to-equity ratio?

Medical Properties Trust Inc (MPT) had a debt-to-equity ratio of 1.83 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Medical Properties Trust Inc's return on assets (ROA)?

Medical Properties Trust Inc (MPT) had a return on assets of -16.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Medical Properties Trust Inc's Piotroski F-Score?

Medical Properties Trust Inc (MPT) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Medical Properties Trust Inc's earnings high quality?

Medical Properties Trust Inc (MPT) has an earnings quality ratio of -0.10x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.